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SUMMARY: The experimental oral carcinogenesis induced by the chemical 4-nitroquinoline 1-oxide (4NQO) is one of the
most frequent in the study of squamous cell carcinoma of the oral cavity (CCEC). The clear advantage is that the model is very similar
to the physiological process of malignancy. The model has clear benefits by and is suitable for applications in therapeutic research.
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INTRODUCTION
Oral cancer, most commonly in tongue, is a major cau-
se of cancer deaths worldwide (Parkin et al., 2001). Oral
squamous cell carcinoma (OSSC) represents 90% of oral
malignancies (Silverman, 2001). Every year more than 300,000
new cases are being diagnosed with OSCC world wide.
The development of malignant neoplasms -including
the oral cancer- is a complex process, and for their
understanding  animal models of carcinogenesis that
accurately represent the cellular and molecular changes
associated with initiation and progression of human oral
cancer have been deployed (Rivera et al., 2011), from nor-
mal tissues to pathological conditions, which are then capable
of being analyzed using histopathologic, genetic and
biochemical techniques (Herzig et al., 2002).
One of the animal models of carcinogenesis most used
is that by chemical induction with 4-nitroquinoline 1-oxide
(4NQO) (Dayan et al., 1997; Rivera et al.). The 4NQO is a
powerful carcinogen in several organs, and it can specifically
induce tongue SCC when applied in low concentrations via
drinking water (El-Rouby, 2011).
The aim of this review is to present the most used
method to induce oral cancer, experimentally.
Carcinogenesis. Carcinogenesis is the process by which
normal cells or tissues become transformed into cancer
(Levy, 1963; Kumar et al., 2005). This implies a
carcinogen, a substance which will transform normal to
malignant cells (Levy et al., 1950). Carcinogens can be
essentially divided into DNA-reactive genotoxic and non-
genotoxic types on the basis of their mechanisms of action.
They can cause initiated cells to develop into preneoplastic
and neoplastic lesions by stimulating clonal proliferation
(Miranda et al., 2011).
A large number of agents  are capable of producing
genetic damage and induce malignant transformation. These
include chemical and physical carcinogens, oncogenic
viruses and some other microorganisms (Kumar et al.; Jiang
et al., 2007; Choi & Myers, 2008).
In the process of carcinogenesis, cellular alterations
at the molecular level are the first to occur, such as alterations
in the genetic material which are not detectable by
conventional histopathology. The accumulation of these
molecular changes over time, causing individual cell changes
that subsequently will be massive and may be detected
histologically, and then when the number of altered cells is
significant, it is possible to observe macroscopic changes in
the affected areas.
Chemical carcinogenesis. Many carcinogenic chemicals
have been identified that are involved in the development of
various tumors. The induction of genetic alterations by
chemical carcinogenesis involves 3 stages: initiation,
promotion and progression.
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Initiation: Is the response to exposure of cells to sufficient
doses of carcinogen (initiator), an initiated cell is altered,
making it potentially capable of giving rise to a tumor.
However, the initiation alone is not sufficient for tumor
formation. The initiation produces permanent damage to the
DNA (mutations), therefore it is irreversible and has memory
(Kumar et al.).
Promotion: This phase is mediated by so-called promoters,
agents that can induce tumors in initiated cells, but which
by themselves are not tumorigenic and can act on the initiated
cells several months after application of the initiator. In
contrast to the effects of the initiators, the cellular changes
resulting from the application promoters do not directly affect
the DNA and are reversible. For example, they can increase
proliferation of initiated cells, an effect that may contribute
to the development of additional mutations (Kumar et al.).
The promotion is reversible in the early stages if the promoter
agent is eliminated (Stevens & Lowe, 2001).
Progression: If it persists in cell proliferation, initiated cells
acquire new genetic alterations in oncogenes, which result
in deregulation of growth and, sometimes, in autonomous
growth. The end point of this progression is the development
of an invasive tumor (Stevens & Lowe).
Although many agents are initiators or promoters,
others behave as both, which defines them as a complete
carcinogen (Stevens & Lowe).
Experimental Oral Carcinogenesis. The main animal
models of carcinogenesis using chemical agents, probably
because the chemical constituents of tobacco and alcohol
were quickly identified as possibly responsible for most
human OSCC (Mognetti et al., 2006).
No animal model is perfectly applicable to any type
of human cancer. However, there is consensus to use an ani-
mal model is an unavoidable step to understanding the
processes and human diseases such as the process of
carcinogenesis and the evaluation of therapeutic
interventions. Experimental animal models that accurately
represent the cellular and molecular changes associated with
the initiation and progression of human cancer, are of crucial
importance, although some are more suited for certain
applications than others (Mognetti et al.).
Early attempts to induce malignant oral tumors were
largely unsuccessful, as the oral mucosa is considerably more
resistant to the actions of chemical carcinogens than skin
(Eveson, 1981). This difference in susceptibility is explained
by the presence of saliva in the oral cavity, which has a
protective effect (Vered et al., 2010).
The first animal model of chemical induced OSCC
was used in Syrian hamsters. These animals have a pocket
on each cheek, whose anatomical feature allows easy access
(MacDonald, 1981). The first successful chemical agent used
was 9,10-dimethyl-1,2-benzanthracene (DMBA), either
dissolved in acetone or benzene (Salley, 1954).
However, application of DMBA is laborious locally.
Also acetone and benzene have local toxic effects.
Additionally, Syrian hamster oral mucosa, despite having a
stratified squamous epithelium, is very different from the
human (MacDonald; Nauta et al., 1995).
Animal models have long been confined to
chemically induced oral carcinomas, probably because the
chemical components of tobacco and alcohol were quickly
identified as responsible for most human OSCC (Mognetti
et al.).
4NQO oral squamous cell carcinoma model. The medium
term tongue carcinogenesis assay is a useful model for
studying OSSC phase by phase. The animal model of
chemical carcinogenesis induced locally or systemically by
4-nitroquinoline-1-oxide (4NQO) is considered the most
representative model to study OSSC (Dayan et al.; Rivera
et al.). This model is based on the multi-step process of
carcinogenesis, which is characterized by initiation,
promotion, and tumor progression (Fracalossi et al., 2011;
Minicucci et al. 2011).
The 4NQO (Fig. 1) is a synthetic carcinogen
derivative of a quinoline, soluble in water, sensitive to high
temperature and light (Wilkey et al., 2009).  Is used to study
the various stages of oral carcinogenesis, because it is capable
of inducing sequentially the phases of carcinogenesis
(hyperplasia, dysplasia, severe dysplasia, carcinoma in situ
and OSSC) (Wilkey et al.). The 4NQO is a powerful
chemical carcinogen whose carcinogenic action is initiated
by the enzymatic reduction of its nitro group (Nagao &
Sugimura, 1976; Kitano, 2000). The four-electron
reduction product 4-hydroxyaminoquinoline 1-oxide
(4HAQO) is believed to be the proximate carcinogenic
metabolite of 4NQO. When metabolized to an electrophilic
reactant, selyl-4HAQO, it reacts with DNA to form stable
quinoline monoadducts such as 3-(deoxyadenosin-N6-yl)-
4AQO and N4-(guanosin-7-yl-4AQO) which are
considered responsible for its mutagenicity and
genotoxicity (Tada & Tada, 1975; Kohdab et al., 1991). 4-
Nitroquinoline 1-oxide (4NQO) elicits its carcinogenicity
by producing DNA adducts after being metabolized to 4-
hydroxyaminoquinoline 1-oxide, which forms 8-
hydroxydeoxyguanosine (8OHdG) which is responsible
for its oxidative damage (Arima, 2006).
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Depending upon the dose and duration of treatment, 4NQO
induces a spectrum of dysplastic and neoplastic lesions in the
oroesophageal epithelium, with morphological and molecular
alterations that mimic those occurring in human oral epithelial
preneoplastic and neoplastic lesions (Wilkey et al.).
The carcinogenic mechanism of action of 4NQO is through
the generation of reactive oxygen species (ROS) and nitrogen
(RNS) such as superoxide radicals, hydrogen
peroxide and nitric oxide, which induce
intracellular oxidative stress (Nunoshiba &
Demple, 1993). ROS/RNS damage directly and
indirectly to macromolecules, including the DNA,
predominantly by binding of guanine residues,
leading to adducts (Kanojia & Vaidya, 2006).
The damage described is similar to those
caused by other carcinogens present in the
tobacco, which is an important risk factor for oral
cancer. Also exposure to 4NQO produces
molecular and cellular changes that lead to
histopathological changes similar to those seen in
human OSCC (Kanojia & Vaidya).
Chronic administration of 4NQO in water
simulates tongue carcinogenesis in rats, similar
to its human homolog (Minicucci et al., 2009).
The oral mucosa of tongue dorsum of mice has
also been used to induce tumors massively, mainly
in strains CBA, C57BL/6, BALB/C and others.
There has been a 100% incidence of lesions in
animals. Histopathological analysis indicated that
these lesions were squamous dysplasias,
papillomas and invasives OSSC (Tang et al.,
2004). Figure 2 shows a well-differentiated
carcinomas induced by 4NQO.
The model of carcinogenesis in rat and
mouse is more appropriate to study OSSC,
Fig. 1. Structures of 4NQO and its metabolites (Koontongkaew et
al., 2000).
RIVERA, M. C. A. 4NQO carcinogenesis: a model of oral squamous cell carcinoma.  Int. J. Morphol., 30(1):309-314, 2012.
Fig. 2. Well-differentiated (A) and moderately differentiated (B) OSSC induced by 4NQO.
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because the oral mucosa of these animals is similar to human
oral mucosa, especially in palate and tongue (MacDonald; Nauta
et al., 1996). Another advantage of this model is the possibility
of chemical management in systemic, long-term and lower doses,
reducing further adverse effects (Vered et al., 2005).
There is a lag time between the onset of molecular changes
(not detectable with conventional light microscopy), the onset of
histopathological changes (detectable) and the macroscopic and
clinical appearance of lesions (MacDonald; Ribeiro et al., 2004;
Vered et al.). Figure 3 shows macroscopic tongue lesions.
The histopathological changes in the tongue epithelium
during carcinogenesis pass from mild to moderate and severe
dysplasia before the onset of OSSC. The initiation, with irrever-
sible cellular changes, occurring within 4 weeks of systemic
administration of 4NQO, through drinking water (Steidler &
Reade, 1986). The latency period between first histopathology
manifestations and macroscopic lesions in this model is 8 weeks
(Salley, 1954, Vered et al.).
Experimental protocols used vary extensively, however,
concentrations of carcinogen used are similar (Steidler & Reade;
Nauta et al., 1996; Vered et al.).
In order to validate models of chemical carcinogenesis in
animals have been developed for comparative studies in humans
and animals OSSC, relative to the carcinogen activation markers,
oxidative stress, cell proliferation, apoptosis, invasion, and
angiogenesis. The results reveal aberrant expression of multiple
molecules in the main signaling pathways in both OSSC (Nagini
et al., 2009), establishing these models of study as an important
tool for monitoring oral oncogenesis.
DISCUSSION
Animal models permit the development and
testing of new approaches to disease prevention
and treatment, identification of early diagnostic
markers and novel therapeutic targets, and an
understanding of the in vivo biology and genetics
of tumor initiation, promotion, progression and
metastasis.
The aim of chemical carcinogenesis model
is to provide further understanding concerning the
multi-step process of carcinogenesis in order to
investigate hazard risk caused by environmental
agents as well as to develop strategies for early
diagnostic and/or cancer prevention (Miranda et
al.).
The 4NQO can be administered orally in
drinking water and therefore is easy to apply (Tang
et al.). This model is effective because of a close
similarity to human oral carcinogenesis at both
histological as well as molecular level. Here,
controlled conditions can be maintained with
limited variations, which allow the reproducible
isolation of all the stages of carcinogenesis and
hence provide an excellent opportunity to intervene
the neoplastic progression, as the premalignant
stages are identifiable. Unfortunately, conditions
often vary from study to study, such as the doses
of 4NQO and species and strains used.
The two most frequent used experimental
procedures for investigating therapies are in vitro
cell lines and the nude mouse. The 4NQO model
has several advantages and disadvantages over
these laboratory experiments. Compared with the
cell lines and the nude mouse model, the close
similarity of the 4NQO model to the physiological
process is a big benefit. The biggest drawback of
the nude mouse model is the lack of an
immunocompetent component. The clear
disadvantage of the 4NQO model is that both the
cell line and the bare mouse are less time
consuming and that cell line experiments are less
costly and most of the time readily available
(Schoop et al., 2009).
Currently it has started to be used
simultaneously 4-NQO (200 µg/ mL) more and
arecoline (500 µg/mL), in order to increase the
incidence of malignant lesions (Chang et al., 2010).
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Fig. 3. Mice tongue lesions induced by 4NQO.
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The 4NQO model is still the most used, however,
transgenic models are very recent and very promising,
considering that the genetics of animals is known, these
models seek to standardize the model of oral carcinogenesis,
an example of them, the K14-CreERtam/LSL-K-rasG12D/
+/p53flox/flox two-hit animal model system (Raimondi et
al., 2009) that may represent a suitable platform for exploring
the underlying molecular mechanism and genetic and
epigenetic event determining the susceptibility to malignant
progression of tumoral lesions arising from the distinct
stratified epithelia of the oral cavity.
In conclusion, taking advantages and disadvantages in
to account the 4NQO oral tumor model has clear benefits and
seems suitable for therapeutic research applications, however
we must remain alert to emerging models.
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RESUMEN: La carcinogénesis oral experimental inducida por el químico 4-nitroquinolina 1-óxido (4NQO) es uno de los
métodos más frecuentes en el estudio del carcinoma de células escamosas de la cavidad oral (CCECO). La clara ventaja del modelo
radica en el gran parecido al proceso fisiológico de la neoplasia maligna. El modelo tiene beneficios claros y es adecuado para las
aplicaciones de la investigación terapéutica.
PALABRAS CLAVE: 4NQO; Carcinogénesis experimental; Carcinoma oral de células escamosas; Lengua.
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